Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other
companies in this sector in China:
Harbin Pharmaceutical Group Company Limited
sales of 10.81 billion Chinese Renmimbi [US$1.53 billion]
of which 65%
was Medicine Trade),
Huapont Life Sciences Co Ltd
(10.57 billion Chinese Renmimbi [US$1.49 billion]
of which 65%
was Agricultural Business), and
Xin Jiang Ready Health Industry Co Ltd
(10.84 billion Chinese Renmimbi [US$1.53 billion]
of which 86%
was Pharmaceutical - Wholesale).
During the year ended December of 2018, sales at
Chongqing Taiji Industry (Group) were 10.69 billion Chinese Renmimbi (US$1.51 billion).
increase of 22.4%
versus 2017, when the company's sales were 8.73 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group)
(and since 2013, sales have increased a total of 62%).
Sales of Service saw an increase
that was more than double the company's growth rate: sales were up
319.8% in 2018, from
12.06 million Chinese Renmimbi to 50.63 million Chinese Renmimbi.
Chongqing Taiji Industry (Group) also saw significant increases in sales in
Industrial (up 43.2% to 7.91 billion Chinese Renmimbi)